Discover

'Danaparoid sodium' (Orgaran®) is an anticoagulant that works by inhibiting activated factor X (factor Xa).
Danaparoid is considered a "low molecular weight heparin" by some sources, but is chemically distinct from heparin and thus has little cross-reactivity in heparin-intolerant patients.

Contents

Uses

Discontinuation

Administration

Side effects

References

External links

Uses

It is used to prevent deep venous clots, particularly in situations with a high risk of clot formation, such as after hip surgery.
It is also used as a heparinoid substitute in heparin-induced thrombocytopenia which may otherwise cause paradoxical thrombosis.

Discontinuation

On August 14, 2002, this drug was withdrawn by Organon International.^[1]

Administration

IV

Side effects

★ Bleeding problems

★ Low platelets, due to a low level of structural similarity between danaparoid and heparin

★ Asthma exacerbations, due to allergies to sulphites contained within the medicine

References

1. Danaparoid (Subcutaneous Route) - MayoClinic.com

External links

★